About Pharmaceutical Industries In India

FORM VI
[See Paragraph 2 and 20(2)]

YEARLY INFORMATION ON TURNOVER AND ALLOCATION OF SALES AND EXPENSES :-

1. Name of the manufacturer.
2. Address of the Registered/Head Office / Factory.
3. Accounting year.
4. Turnover of Bulk Drugs;-

Sl.No	Name of the Bulk Drug	Unit	Production Quantity	Captive Consumption		Domestic Sale		Exports
				Quantity	Value Excl.ED (Rs. Lakhs)	Quantity	Sale Value Excl.ED (Rs.Lakhs)	Quantity	FOB Value (Rs. Lakhs)
1	2	3	4	5	6	7	8	9	10

SCHEDULED BULK DRUGS
1.
2.
3 etc
NON-SCHEDULED BULK DRUGS
1.
2.
3.etc
TOTAL

I. SCHEDULED FORMULATIONS
1. Own Produced
2. Purchased
   (a) Indigenous
   (b) Imported
II. NON-SCHEDULED BULK DRUGS
1. Own Produced
2. Purchased
(a) Indigenous
(b) Imported
---------------------------------------------------------------------------------
TOTAL
---------------------------------------------------------------------------------
6.Allocation of sales and expenses as shown in the Audited Profit & Loss Account (In Rupees)

S.No.	Particulars	Total as per P&L account	Allocation to bulk drugs own produced	Allocation to Formulations				Other activities	Basis of Allocation
				Purchased		Export Sales	Total
				Indigenous	Imported
1	2	3	4	5	6	7	8	9	10

A. INCOME

1. Sales Income (Excl. Excise duty and other taxes)
2. Cash Subsidy (if any)
3. Other Income (Incl. Import incentives

---------------------------------------------------------------------------------
TOTAL (1+2+3)
--------------------------------------------------------------------------------
B. EXPENSES


4. Raw Materials
5. Packing Materials
6. Power & Fuel
7. Salaries and Wages
8. Stores and Spares
9. Repair and Maintenance
10. Insurance
11. Depreciation
12. Royalty
13. Interest
14. Head Office-Expenses
15. Dealer's Commission and Discount
16. Research and Development Expenses
17. Other Expenses

------------------------------------------------------------------------------
TOTAL (4 TO 17)
------------------------------------------------------------------------------
C. PROFIT BEFORE TAX (A-B)
D. PROFIT BEFORE TAX (As a %age of Sales income)
[C x 100/A]

NOTES:

1. The basis of allocation should be reasonable and followed consistently.
2. The figures against S. No . A under Cols. 4 to 9 of item 6 should tally with the figures under items 4 and 5 respectively of this form
3. This form should be certified by the Company's Auditors.

The information furnished above is correct and true to the best of my knowledge and belief.

Authorised Signatory:

Place:           Name:
Date:            Designation: